Diagnostic Comparison of PET-magnetic Resonance and PET-CT in Patients With Oncologic Diseases
Completed
- Conditions
- Neoplasm Staging
- Registration Number
- NCT02316431
- Lead Sponsor
- University of Zurich
- Brief Summary
Diagnostic accuracy of PET/magnetic resonance and PET/CT will be compared concerning primary tumor, regional nodes, metastasis (TNM) staging and therapeutic influence. Workflow scenarios will be evaluated to create imaging protocols which are time efficient and diagnostically accurate.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 142
Inclusion Criteria
- Male and female patients from 18-90 years
- Written informed consent
- Patients with a proven or suspected oncological disease referred for a clinically -Indicated PET/CT with of without contrast media
Read More
Exclusion Criteria
- Pregnant or breast feeding women
- Non compliance of the patient to follow the study instructions (e.g. hearing problems, dementia)
- Inclusion in another clinical trial 30 days prior to inclusion
- Age < 30years
- Contraindication for MRI (cardiac pacemaker, certain metal implants, claustrophobia
- Known allergies to contrast CT or MRI contrast media
- Patients with an glomerular filtration rate of < 60ml/min/1.73m2
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of patients with correct TNM staging defined with PET/magnetic resonance versus PET/CT 12 month
- Secondary Outcome Measures
Name Time Method Number of minutes needed per PET/magnetic resonance protocol compared to PET/CT 12 month
Trial Locations
- Locations (1)
University Hospital Zurich, Diagnostic and Interventional Radiology
🇨ðŸ‡Zurich, Switzerland